Tumor−host interactions in the gallbladder suppress distal angiogenesis and tumor growth: Involvement of transforming growth factor 1
Takeshi Gohongi1, Dai Fukumura1, Yves Boucher1, Chae-Ok Yun1, Gerald A. Soff2, Carolyn Compton3, Takeshi Todoroki4
& Rakesh K. Jain1
1
Edwin L. Steele Laboratory, Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston Massachusetts 02114, USA
2
Department of Medicine, Division of Hematology/Oncology, Northwestern University Medical School, Chicago, Illinois 60611, USA
3
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston Massachusetts 02114, USA
4
Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Ibaraki 305, Japan
Angiogenesis inhibitors produced by a primary tumor can create a systemic anti-angiogenic environment and maintain metastatic tumor cells in a state of dormancy1,
2. We show here that the gallbladder microenvironment modulates the production of transforming growth factor (TGF)-1, a multifunctional cytokine that functions as an endogenous anti-angiogenic and anti-tumor factor in a cranial window preparation. We found that a wide variety of human gallbladder tumors express TGF-1 irrespective of histologic type. We implanted a gel impregnated with basic fibroblast growth factor3 or Mz-ChA-2 tumor in the cranial windows of mice without tumors or mice with subcutaneous or gallbladder tumors to study angiogenesis and tumor growth at a secondary site. Angiogenesis, leukocyte−endothelial interaction in vessels and tumor growth in the cranial window were substantially inhibited in mice with gallbladder tumors. The concentration of TGF-1 in the plasma of mice with gallbladder tumors was 300% higher than that in the plasma of mice without tumors or with subcutaneous tumors. In contrast, there was no difference in the plasma levels of other anti- and pro-angiogenic factors. Treatment with neutralizing antibody against TGF-1 reversed both angiogenesis suppression and inhibition of leukocyte rolling induced by gallbladder tumors. TGF-1 also inhibited Mz-ChA-2 tumor cell proliferation. Our results indicate that the production of anti-angiogenesis/proliferation factors is regulated by tumor−host interactions.
1
1, a multifunctional cytokine that functions as an endogenous anti-angiogenic and anti-tumor factor in a cranial window preparation. We found that a wide variety of human gallbladder tumors express TGF-
